Skip to content

SGMOQ SANGAMO THERAPEUTICS INC

Follow

COM (common), issuer CIK 1001233

6 managers (6 13F filers) reported a position in SGMOQ shares at 2026-06-30, 533,408 shares in all. 2 filers opened a position and 107 filers sold out during the quarter.

Managers
6
13F filers
6
New
2
Added
1
Reduced
0
Sold out
107
Shares held by filers
533,408

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
NOMURA ASSET MANAGEMENT INTERNATIONAL I…in group NOMURA ASSET MANAGEMENT CO LTD400,000$22K<0.01%013F-HRTimelineGroup
SIMPLEX TRADING, LLC76,500$4.13K<0.01%new13F-HRTimeline
Axiom Investment Management LLC25,375$1.37K<0.01%013F-HRTimeline
FLOW TRADERS U.S. LLC21,532$1K<0.01%+3413F-HRTimeline
Heritage Investment Group, Inc.10,000$539<0.01%new13F-HRTimeline
BARCLAYS PLCin group BARCLAYS PLC1$00%013F-HRTimelineGroupValue filed as zero, left out of ratios.

Events

  • ARMISTICE CAPITAL, LLC and 1 other reporting person reported 40,560,819 SGMOQ shares, 9.79% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001172661-26-005253

    Accepted , ingested